Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B vaccine -- do we need boosters?

J E Banatvala1, P Van Damme

  • 1Clinical Virology, Guys Kings and St Thomas' School of Medicine and Dentistry, Clinical Virology, London, UK. jangu@church-end-henham.co.uk

Journal of Viral Hepatitis
|February 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

140&#x2003;Effect of lycopene supplementation to bovine oocytes exposed to heat shock during <i>in vitro</i> maturation.

Reproduction, fertility, and development·2022
Same author

Animal experiments show impact of vaccination on reduction of SARS-CoV-2 virus circulation: A model for vaccine development?

Biologicals : journal of the International Association of Biological Standardization·2021
Same author

Effect of lycopene supplementation to bovine oocytes exposed to heat shock during in vitro maturation.

Theriogenology·2021
Same author

Necrosome-positive granulovacuolar degeneration is associated with TDP-43 pathological lesions in the hippocampus of ALS/FTLD cases.

Neuropathology and applied neurobiology·2020
Same author

Amyotrophic lateral sclerosis: a clinical review.

European journal of neurology·2020
Same author

In vitro antimicrobial combinatory effect of Cinnamomum cassia essential oil with 8-hydroxyquinoline against Staphylococcus aureus in liquid and vapour phase.

Journal of applied microbiology·2020

Hepatitis B vaccination provides long-term protection through immune memory, not just antibody levels. Booster doses are unnecessary for immunocompetent individuals, offering significant global cost benefits.

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Hepatitis B (HB) infection poses a significant global health challenge.
  • Long-term efficacy of HB vaccination is crucial for disease prevention.
  • Understanding immune memory post-vaccination is key to optimizing immunization strategies.

Purpose of the Study:

  • To analyze long-term follow-up data on hepatitis B vaccination efficacy.
  • To evaluate the role of immune memory versus antibody levels in vaccine protection.
  • To assess the need for booster doses in immunocompetent individuals.

Main Methods:

  • Systematic review of long-term follow-up studies in diverse populations.
  • Analysis of antibody responses (anti-HBs, anti-HBc) and viral markers (HBsAg).

Related Experiment Videos

  • Assessment of immune memory through challenge studies and B-cell responses (ELISA).

    • Main Results:

    • Low or undetectable antibody levels years post-vaccination did not lead to disease or carrier states.
    • Immune memory was confirmed by anamnestic responses and T-cell proliferation.
    • Protection appears dependent on established immune memory, not sustained antibody titers.

    Conclusions:

    • Hepatitis B vaccination confers durable protection via immune memory.
    • Booster doses are not required for immunocompetent individuals after a complete vaccination course.
    • Eliminating booster doses offers substantial worldwide cost benefits and simplifies vaccination programs.